Description
A DOPA decarboxylase inhibitor (ED50 = 21.8 mg/kg); α2-adrenergic receptor agonist; metabolized to α-methylnorepinephrine in the CNS; has antihypertensive activity in vitro and in vivo; improves trophoblast and endothelial cellular interaction in vitro
Formal name: 3-hydroxy-α-methyl-L-tyrosine
Synonyms: Methyldopa|MK-351|NSC 169916
Molecular weight: 211.2
CAS: 555-30-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Vasculature|Endothelium||Research Area|Endocrinology & Metabolism|Reproductive Biology